Buprenorphine Hydrochloride Sublingual
Product Images NDC 67046-997

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride Sublingual (NDC 67046-997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Hydrochloride Sublingual Tablets Ciii 2 mg Bottle Label (D2288167 C532 4fb4 Abe3 F362492b9e5a 03)

Buprenorphine sublingual tablets are available in packs of 30. Each tablet contains 2.16 mg of Buprenorphine HCI which is equivalent to 2 mg of buprenorphine base. These tablets are classified as a controlled substance and should be stored at a temperature of 20-25°C. The CPS NDC for these tablets is 67046-996-30. The prescribing information is not available in the given text.*

FDA Label Image

Buprenorphine Hydrochloride Sublingual Tablets Ciii 8 mg Bottle Label (D2288167 C532 4fb4 Abe3 F362492b9e5a 04)

Buprenorphine Sublingual is a controlled medication available in the form of 8 mg tablets packed in a bottle of 30 tablets. The medication contains 8.84mg of buprenorphine HCl equivalent to 8 mg of buprenorphine base. It is prescribed in accordance with accompanying prescribing information. The lot number of the medication is TEST, and the pill ID is M 924. The medication is packaged by Contract Pharmacy Services in Pennsylvania. The storage recommendation for the medication is 20-25°C (88-77°F). The CPSNDC number of the medication is 67046-997-30.*

FDA Label Image

Buprenorphine Hydrochloride Structural Formula (Image 01)

FDA Label Image

Medication Guide Tablet Placement (Image 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.